Torley Helen sold HALO
December 1, 2025 · Form 4 insider transaction
Torley Helen sold 261 shares of Halozyme Therapeutics, Inc. at $71.60 per share, a transaction worth $18.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
261
Price
$71.60
Total value
$18.7K
InsiderTorley Helen
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 1, 2025
Filing dateDecember 1, 2025
Shares owned after708,719
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in less than one year in February 2026.